Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2010
09/15/2010CN101829258A Chinese medicinal composition preparation for strengthening spleen and stomach, enriching blood and promoting secretion of body fluid and quality control method
09/15/2010CN101829252A Footbath effervescent tablet for improving sub-health
09/15/2010CN101829228A Method for extracting digitonin
09/15/2010CN101829223A Traditional Chinese medicine composition for treating myelofibrosis anemi
09/15/2010CN101829183A Traditional Chinese medicine preparation for preventing and curing cerebral and vascular diseases by principle that anti-platelet volume is abnormal
09/15/2010CN101829176A Method for identifying rhizoma atractylodis macrocephalae by adopting thin layer chromatography
09/15/2010CN101829170A Extract of panax notoginseng saponins and preparation method thereof
09/15/2010CN101829158A Pig blood composition and pig blood chewable tablet made therefrom
09/15/2010CN101829129A Veterinary compound gentamycin sulfate injection and preparation method thereof
09/15/2010CN101829116A PTEN inhibitor or MAXI-K channels opener
09/15/2010CN101829109A Bilobalide with aquaporin regulating effect and new use of derivative thereof in treating encephaledema
09/15/2010CN101829054A Alprostadil submicron emulsion for injection and preparing method thereof
09/15/2010CN101601647B Riboflavine sodium phosphate composition injection and preparation method thereof
09/15/2010CN101245110B Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition
09/15/2010CN101210239B Double-functional molecule for dissolving thrombus and inhibiting blood platelet aggregate and use thereof
09/15/2010CN101139578B Double-functional staphylokinase mutant having platelet aggregation resistance and fibrinolytic activity, application and preparation method thereof
09/15/2010CN101125205B Polyethylene decorative nevin fibrinolytic enzyme and its preparation method
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795293 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/14/2010US7795289 Use of acylaminothiazole derivatives as therapeutic agents
09/14/2010US7795281 (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester; calcium antagonistic action, antihypertensive action, vascular dilatory action, cardiac protective action, anti-arteriosclerotic action, diuretic action
09/14/2010US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
09/14/2010CA2441501C Rho-kinase inhibitors
09/14/2010CA2415558C Acid addition salts of hydropyridine derivatives
09/14/2010CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase
09/14/2010CA2399395C Arginine mimetics as factor xa inhibitors
09/10/2010WO2010102283A2 Hemostatic agent composition, delivery system and method
09/10/2010WO2010102216A2 Enhancing coagulation or reducing fibrinolysis
09/10/2010WO2010101237A1 Polypeptides and antibacterial or antiseptic use of same
09/10/2010WO2010100385A1 Novel uses of fibrinogen
09/10/2010WO2010083320A3 Methods and compositions for the inhibition of thrombus formation
09/10/2010CA2754549A1 Enhancing coagulation or reducing fibrinolysis
09/10/2010CA2754399A1 Novel uses of fibrinogen
09/09/2010US20100227873 Nitrogen-containing heterocyclic compounds and methods of use thereof
09/09/2010US20100227860 Disalt inhibitors of il-12 production
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/09/2010US20100227830 Use of escin
09/09/2010US20100227823 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
09/09/2010US20100226970 Cationic liposome delivery of taxanes to angiogenic blood vessels
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226918 Pyrrole derivatives as p2y12 antagonists
09/09/2010US20100226911 Treating or preventing extracellular matrix build-up
09/08/2010EP2226385A1 Human Coagulation Factor VII Variants
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226085A1 Anti-angiogenic compositions and methods of use
09/08/2010EP2226070A1 Process for determining the optimal dosage of antivitamins K in anticoagulant therapy
09/08/2010EP2224927A1 Pterin analog for treating bh4 responsive condition
09/08/2010EP2224926A1 Prolyl hydroxylase inhibitors
09/08/2010EP2224922A2 Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the tnf- levels and an exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative
09/08/2010EP2224909A1 Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds
09/08/2010EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1406697B1 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement
09/08/2010CN1985662B Health beverage capable of lowering blood viscosity
09/08/2010CN1973853B Hemostatic and analgetic medicine composition and its preparation process
09/08/2010CN1899448B Chinese medicine compound preparation for treating amblyopia and its preparing method
09/08/2010CN1891255B Blood total flavone extract, and its preparing method and use
09/08/2010CN1850078B Anti-platelet aggregation medicinal injection and its preparing method
09/08/2010CN1842341B Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng
09/08/2010CN1816327B Use of HIF alpha stabilizers for enhancing erythropoiesis
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/08/2010CN101827864A Liquid formulation of G-CSF conjugate
09/08/2010CN101824455A Soy protein oligopeptide, and preparation method and use thereof
09/08/2010CN101824091A G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof
09/08/2010CN101822788A Traditional Chinese patent drug for treating cardiovascular and cerebrovascular diseases
09/08/2010CN101822770A Medicinal composition with anti-tumor effect and application thereof
09/08/2010CN101822766A Preparation method of deer antler wine
09/08/2010CN101822758A Externally applied Chinese patent medicine for treating cerebral thrombosis and preparation method thereof
09/08/2010CN101822731A Raspberry leaf extract and application thereof in preparing anticoagulant and antithrombotic medicine
09/08/2010CN101822692A Method for removing hemolytic toxicity from physaliatoxin
09/08/2010CN101822690A Composition of dextran 40 and sodium lactate Ringer' solution and preparation method
09/08/2010CN101822658A Cysteamines for treating complications of hypercholesterolemia and diabetes
09/08/2010CN101822654A Pentetate inhalant
09/08/2010CN101822367A Medicine combination with function of improving nutritional anemia and preparation method thereof
09/08/2010CN101518617B Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same
09/08/2010CN101416939B Puerarin liquid formulation and preparation method thereof
09/08/2010CN101182355B Antibacterial peptide citropin 1.18 fusion protein
09/08/2010CN101156863B A medicine composition for treating cardiac and cerebral vascular disease and its medical usage
09/08/2010CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790749 Antiulcer agents; gastrointestinal disorders; anticancer agents; anemia
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010US7790680 Hemophilia biodrug recombinant porcine factor 8 formulation with replacement for albumin stabilizer, which may carry risk of prions; surfactant such as polysorbate, calcium chloride, sucrose, sodium chloride, trisodium citrate, and a buffer devoid of amino acids
09/07/2010US7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives
09/02/2010WO2010098079A1 Method for denucleating nucleated erythrocyte, and denucleation inducer
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222412 Modulation of glucocorticoid receptor expression
09/02/2010US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives
09/02/2010US20100222361 2-acylaminothiazole derivative or salt thereof
09/02/2010US20100222347 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient
09/02/2010US20100222329 2-acylaminothiazole derivative or salt thereof
09/02/2010US20100222297 Cell wall derivatives, their preparation process, and use thereof
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 671